Live Breaking News & Updates on Williamm Sikov

Stay updated with breaking news from Williamm sikov. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr Sikov on the Use of CDK4/6 Inhibitors in the First-line Treatment of ER+/HER2- Breast Cancer

William M. Sikov, MD, discusses the negative outcome seen with palbociclib in the phase 3 PALOMA-2 trial, and compares this to data on other CDK4/6 inhibitors in the first-line treatment of estrogen receptor–positive, HER2-negative breast cancers. ....

Rhode Island , United States , Williamm Sikov , Lifespan Educational Advisory Committee , Lifespan Cancer Institute , Infants Hospital , Onclive Tv , Breast Cancer , Cdk4 6 Inhibitors , Her2 Negative Breast Cancers , Hr Positive Breast Cancer ,

Recent Approvals Support Continued Research on New and Emerging ADCs Across Breast Cancer Subtypes

Stephanie L. Graff, MD, gives an overview of recently approved ADCs in TNBC and HR-positive, HER2-negative breast cancer, as well as the importance of continued research with these agents in the first-line setting.
....

Rhode Island , United States , Stephaniel Graff , Daiichi Sankyo , Mary Ann Fenton , Williamm Sikov , Eli Lilly , National Comprehensive Cancer Network , Lifespan Cancer Institute , Brown University Legorreta Cancer Center , Warren Alpert Medical School , Breast Cancer Translational Research Disease Group , American Society Of Clinical Oncology , Institutional Perspectives , Breast Oncology , Brown University , Legorreta Cancer Center , New England Journal , Onclive State , Lifespan Cancer , American Society , Clinical Oncology ,

Dr Sikov on the Benefit of CDK4/6 Inhibitors in HR+/HER2-Negative Breast Cancer

William M. Sikov, MD, discusses the benefit of CDK4/6 inhibitors in the treatment of hormone receptor–positive/HER2-negative breast cancers. ....

Rhode Island , United States , Williamm Sikov , Lifespan Cancer Institute , Lifespan Educational Advisory Committee , Infants Hospital , Onclive Tv , Breast Cancer , Cdk4 6 Inhibitors , Her2 Negative Breast Cancers , Hr Positive Breast Cancer ,